Yang Cheng

2.3k total citations
41 papers, 1.5k citations indexed

About

Yang Cheng is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yang Cheng has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Yang Cheng's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (10 papers) and Hepatitis B Virus Studies (6 papers). Yang Cheng is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (10 papers) and Hepatitis B Virus Studies (6 papers). Yang Cheng collaborates with scholars based in China, United States and Singapore. Yang Cheng's co-authors include Evan W. Newell, Patrick Kennedy, Tobias Boettler, Étienne Becht, Matthias von Herrath, Antonio Bertoletti, Pooja Khanna, William Rosenberg, Dimitra Peppa and Anna Schurich and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Immunity.

In The Last Decade

Yang Cheng

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Cheng China 18 797 489 372 343 209 41 1.5k
Lauren E. Holz Australia 17 781 1.0× 457 0.9× 156 0.4× 506 1.5× 153 0.7× 33 1.4k
Aaron J. Tyznik United States 15 1.9k 2.4× 235 0.5× 298 0.8× 73 0.2× 363 1.7× 28 2.2k
Valérie Depraetere France 7 984 1.2× 287 0.6× 748 2.0× 99 0.3× 259 1.2× 10 1.7k
Meijuan Zheng China 20 785 1.0× 268 0.5× 390 1.0× 183 0.5× 435 2.1× 58 1.6k
Dirk Wohlleber Germany 17 866 1.1× 360 0.7× 329 0.9× 284 0.8× 487 2.3× 33 1.5k
Armanda Casrouge France 22 2.0k 2.6× 394 0.8× 410 1.1× 127 0.4× 646 3.1× 36 2.7k
Ko Okumura Japan 19 995 1.2× 118 0.2× 501 1.3× 71 0.2× 198 0.9× 48 1.7k
Florian Weisel United States 21 2.1k 2.7× 456 0.9× 630 1.7× 37 0.1× 246 1.2× 27 3.0k
Holly L. Hanson United States 9 1.0k 1.3× 621 1.3× 230 0.6× 782 2.3× 318 1.5× 9 1.8k

Countries citing papers authored by Yang Cheng

Since Specialization
Citations

This map shows the geographic impact of Yang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Cheng more than expected).

Fields of papers citing papers by Yang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Cheng. The network helps show where Yang Cheng may publish in the future.

Co-authorship network of co-authors of Yang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Cheng. A scholar is included among the top collaborators of Yang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Cheng. Yang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Zhengchen, Bowen Shi, Yun Zhang, et al.. (2024). CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway. iScience. 27(2). 108843–108843. 5 indexed citations
2.
Cheng, Yang, et al.. (2024). Chronic viral infection impairs immune memory to a different pathogen. PLoS Pathogens. 20(3). e1012113–e1012113.
4.
Li, Qiong, Xinlei Li, Chao Yang, et al.. (2023). Reverse effect of Semaphorin-3F on rituximab resistance in diffuse large B-cell lymphoma via the Hippo pathway. Chinese Medical Journal. 136(12). 1448–1458. 2 indexed citations
5.
Zhang, Xuan, Di Xia, Ruixian Wang, et al.. (2022). Identification of potential biomarkers for digestive system cancers from serum-derived extracellular vesicle RNA. Clinica Chimica Acta. 531. 36–47. 5 indexed citations
6.
Wu, Wanqing, Longzhi Tan, Cheng Tang, et al.. (2021). Coordination of two enhancers drives expression of olfactory trace amine-associated receptors. Nature Communications. 12(1). 3798–3798. 15 indexed citations
7.
Mattox, Austin K., Jessica Roelands, Talia M. Saal, et al.. (2021). Myeloid Cells Are Enriched in Tonsillar Crypts, Providing Insight into the Viral Tropism of Human Papillomavirus. American Journal Of Pathology. 191(10). 1774–1786. 9 indexed citations
8.
Bert, Nina Le, Upkar S. Gill, Michelle Hong, et al.. (2020). Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection. Gastroenterology. 159(2). 652–664. 108 indexed citations
10.
Luo, Zhigang, et al.. (2020). RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation. Biochemical and Biophysical Research Communications. 530(2). 425–431. 18 indexed citations
11.
Dress, Regine J., Charles‐Antoine Dutertre, Amir Giladi, et al.. (2019). Plasmacytoid dendritic cells develop from Ly6D+ lymphoid progenitors distinct from the myeloid lineage. Nature Immunology. 20(7). 852–864. 154 indexed citations
12.
Cheng, Yang, Yuan Zhu, Étienne Becht, et al.. (2019). Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection. Science Immunology. 4(32). 58 indexed citations
13.
Fang, Ru, Qiuyuan Xia, Jing Sun, et al.. (2019). Hypermethylation of BRM promoter plays oncogenic roles in development of clear cell renal cell carcinoma. Journal of Cancer. 10(21). 5256–5263. 4 indexed citations
14.
Becht, Étienne, Yannick Simoni, Elaine Coustan‐Smith, et al.. (2018). Reverse-engineering flow-cytometry gating strategies for phenotypic labelling and high-performance cell sorting. Bioinformatics. 35(2). 301–308. 17 indexed citations
15.
Newell, Evan W. & Yang Cheng. (2016). Mass cytometry: blessed with the curse of dimensionality. Nature Immunology. 17(8). 890–895. 84 indexed citations
16.
Cheng, Yang & Evan W. Newell. (2016). Deep Profiling Human T Cell Heterogeneity by Mass Cytometry. Advances in immunology. 131. 101–134. 17 indexed citations
17.
Wang, Zhiwei, et al.. (2016). HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells. Molecular Medicine Reports. 14(1). 1026–1032. 12 indexed citations
18.
Cheng, Yang, Michael T. Wong, Laurens van der Maaten, & Evan W. Newell. (2015). Categorical Analysis of Human T Cell Heterogeneity with One-Dimensional Soli-Expression by Nonlinear Stochastic Embedding. The Journal of Immunology. 196(2). 924–932. 49 indexed citations
19.
Boettler, Tobias, Yang Cheng, Katrin Ehrhardt, & Matthias von Herrath. (2012). TGF-β Blockade Does Not Improve Control of an Established Persistent Viral Infection. Viral Immunology. 25(3). 2014210947–2014210947. 27 indexed citations
20.
Fousteri, Georgia, Jean Jasinski, Maki Nakayama, et al.. (2012). Following the Fate of One Insulin-Reactive CD4 T cell. Diabetes. 61(5). 1169–1179. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026